Literature DB >> 11581269

Polycystin-1 interacts with intermediate filaments.

G M Xu1, T Sikaneta, B M Sullivan, Q Zhang, M Andreucci, T Stehle, I Drummond, M A Arnaout.   

Abstract

Polycystin-1, the protein defective in a majority of patients with autosomal dominant polycystic kidney disease, is a ubiquitously expressed multi-span transmembrane protein of unknown function. Subcellular localization studies found this protein to be a component of various cell junctional complexes and to be associated with the cytoskeleton, but the specificity and nature of such associations are not known. To identify proteins that interact with the polycystin-1 C-tail (P1CT), this segment was used as bait in a yeast two-hybrid screening of a kidney epithelial cell library. The intermediate filament (IF) protein vimentin was identified as a strong polycystin-1-interacting partner. Cytokeratins K8 and K18 and desmin were also found to interact with P1CT. These interactions were mediated by coiled-coil motifs in polycystin-1 and IF proteins. Vimentin, cytokeratins K8 and K18, and desmin also bound directly to P1CT in GST pull-down and in in vitro filament assembly assays. Two observations confirmed these interactions in vivo: (i) a cell membrane-anchored form of recombinant P1CT decorated the IF network and was found to associate with the cytoskeleton in detergent-solubilized cells and (ii) endogenous polycystin-1 distributed with IF at desmosomal junctions. Polycystin-1 may utilize this association for structural, storage, or signaling functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581269     DOI: 10.1074/jbc.M107828200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Effect of PKD1 gene missense mutations on polycystin-1 membrane topogenesis.

Authors:  Nancy M Nims; Dianne Vassmer; Robin L Maser
Journal:  Biochemistry       Date:  2010-12-29       Impact factor: 3.162

2.  Polycystins and mechanotransduction: From physiology to disease.

Authors:  Christina Piperi; Efthimia K Basdra
Journal:  World J Exp Med       Date:  2015-11-20

3.  The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation.

Authors:  Steve Mangos; Pui-ying Lam; Angela Zhao; Yan Liu; Sudha Mudumana; Aleksandr Vasilyev; Aiping Liu; Iain A Drummond
Journal:  Dis Model Mech       Date:  2010-03-24       Impact factor: 5.758

Review 4.  Intermediate filaments: a role in epithelial polarity.

Authors:  Andrea S Oriolo; Flavia A Wald; Victoria P Ramsauer; Pedro J I Salas
Journal:  Exp Cell Res       Date:  2007-03-12       Impact factor: 3.905

Review 5.  ADPKD: molecular characterization and quest for treatment.

Authors:  Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 6.  Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.

Authors:  Robert J Kolb; Surya M Nauli
Journal:  Front Biosci       Date:  2008-05-01

Review 7.  Polycystins and partners: proposed role in mechanosensitivity.

Authors:  Kevin Retailleau; Fabrice Duprat
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

8.  Impaired formation of desmosomal junctions in ADPKD epithelia.

Authors:  Ryan J Russo; Hervé Husson; Dominique Joly; Nikolay O Bukanov; Natacha Patey; Bertrand Knebelmann; Oxana Ibraghimov-Beskrovnaya
Journal:  Histochem Cell Biol       Date:  2005-09-27       Impact factor: 4.304

9.  Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion.

Authors:  Ana P Bastos; Klaus Piontek; Ana M Silva; Dino Martini; Luis F Menezes; Jonathan M Fonseca; Ivone I Fonseca; Gregory G Germino; Luiz F Onuchic
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

10.  Homophilic and heterophilic polycystin 1 interactions regulate E-cadherin recruitment and junction assembly in MDCK cells.

Authors:  Andrew J Streets; Bart E Wagner; Peter C Harris; Christopher J Ward; Albert C M Ong
Journal:  J Cell Sci       Date:  2009-04-07       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.